Rigel Pharmaceuticals Stock Volatility
| RIGL Stock | USD 20.20 0.17 0.83% |
Rigel Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Rigel Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0821, which implies the firm had a 0.0821 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Rigel Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Rigel Pharmaceuticals' Risk Adjusted Performance of 0.047, semi deviation of 3.6, and Coefficient Of Variation of 2273.06 to confirm if our risk estimates are consistent with your expectations. Key indicators related to Rigel Pharmaceuticals' volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Rigel Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Rigel daily returns, and it is calculated using variance and standard deviation. We also use Rigel's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Rigel Pharmaceuticals volatility.
Rigel |
ESG Sustainability
While most ESG disclosures are voluntary, Rigel Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Rigel Pharmaceuticals' managers and investors.Environmental | Governance | Social |
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Rigel Pharmaceuticals at lower prices. For example, an investor can purchase Rigel stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes.
Moving together with Rigel Stock
Moving against Rigel Stock
| 0.7 | CDIO | Cardio Diagnostics | PairCorr |
| 0.67 | CRNX | Crinetics Pharmaceuticals | PairCorr |
| 0.56 | ELVN | Enliven Therapeutics | PairCorr |
| 0.51 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
| 0.5 | SCLX | Scilex Holding | PairCorr |
| 0.44 | CDIOW | Cardio Diagnostics | PairCorr |
Rigel Pharmaceuticals Market Sensitivity And Downside Risk
Rigel Pharmaceuticals' beta coefficient measures the volatility of Rigel stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Rigel stock's returns against your selected market. In other words, Rigel Pharmaceuticals's beta of 2.01 provides an investor with an approximation of how much risk Rigel Pharmaceuticals stock can potentially add to one of your existing portfolios. Rigel Pharmaceuticals shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Rigel Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Rigel Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Rigel Pharmaceuticals Demand TrendCheck current 90 days Rigel Pharmaceuticals correlation with market (Dow Jones Industrial)Rigel Beta |
Rigel standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.42 |
It is essential to understand the difference between upside risk (as represented by Rigel Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Rigel Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in rigel stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Rigel Pharmaceuticals.
Using Rigel Put Option to Manage Risk
Put options written on Rigel Pharmaceuticals grant holders of the option the right to sell a specified amount of Rigel Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Rigel Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Rigel Pharmaceuticals' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Rigel Pharmaceuticals will be realized, the loss incurred will be offset by the profits made with the option trade.
Rigel Pharmaceuticals' PUT expiring on 2025-06-20
Profit |
| Rigel Pharmaceuticals Price At Expiration |
Current Rigel Pharmaceuticals Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | RIGL250620P00012000 | -0.117784 | 0.016382 | 4 | 2025-06-20 | 0.0 - 1.85 | 0.0 | View |
Put | RIGL250620P00014000 | -0.158308 | 0.023952 | 1 | 2025-06-20 | 0.0 - 2.15 | 0.0 | View |
Put | RIGL250620P00015000 | -0.185618 | 0.028672 | 11 | 2025-06-20 | 0.0 - 2.4 | 0.0 | View |
Put | RIGL250620P00016000 | -0.199982 | 0.037726 | 15 | 2025-06-20 | 0.0 - 2.0 | 0.0 | View |
Put | RIGL250620P00018000 | -0.300283 | 0.047888 | 1 | 2025-06-20 | 0.0 - 3.4 | 0.0 | View |
Put | RIGL250620P00020000 | -0.399352 | 0.044972 | 11 | 2025-06-20 | 1.0 - 5.4 | 0.0 | View |
Put | RIGL250620P00021000 | -0.461457 | 0.054032 | 7 | 2025-06-20 | 1.5 - 5.1 | 0.0 | View |
Put | RIGL250620P00023000 | -0.551342 | 0.051304 | 4 | 2025-06-20 | 3.1 - 6.4 | 0.0 | View |
Rigel Pharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which Rigel Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Rigel Pharmaceuticals' price changes. Investors will then calculate the volatility of Rigel Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Rigel Pharmaceuticals' volatility:
Historical Volatility
This type of stock volatility measures Rigel Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Rigel Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Rigel Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Rigel Pharmaceuticals' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Rigel Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Rigel Pharmaceuticals Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 2.0079 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Rigel Pharmaceuticals will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Rigel Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Rigel Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Rigel stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Rigel Pharmaceuticals has an alpha of 0.318, implying that it can generate a 0.32 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Rigel Pharmaceuticals Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Rigel Pharmaceuticals Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Rigel Pharmaceuticals is 1218.35. The daily returns are distributed with a variance of 19.52 and standard deviation of 4.42. The mean deviation of Rigel Pharmaceuticals is currently at 3.27. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.89
α | Alpha over Dow Jones | 0.32 | |
β | Beta against Dow Jones | 2.01 | |
σ | Overall volatility | 4.42 | |
Ir | Information ratio | 0.06 |
Rigel Pharmaceuticals Stock Return Volatility
Rigel Pharmaceuticals historical daily return volatility represents how much of Rigel Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 4.4177% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.8377% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Rigel Pharmaceuticals Volatility
Volatility is a rate at which the price of Rigel Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Rigel Pharmaceuticals may increase or decrease. In other words, similar to Rigel's beta indicator, it measures the risk of Rigel Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Rigel Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 290.2 M | 275.7 M |
Rigel Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Rigel Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Rigel Pharmaceuticals' price varies over time.
3 ways to utilize Rigel Pharmaceuticals' volatility to invest better
Higher Rigel Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Rigel Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Rigel Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Rigel Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Rigel Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Rigel Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Rigel Pharmaceuticals Investment Opportunity
Rigel Pharmaceuticals has a volatility of 4.42 and is 5.26 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Rigel Pharmaceuticals is lower than 39 percent of all global equities and portfolios over the last 90 days. You can use Rigel Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a moderate downward daily trend and can be a good diversifier. Check odds of Rigel Pharmaceuticals to be traded at $19.8 in 90 days.Very weak diversification
The correlation between Rigel Pharmaceuticals and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Rigel Pharmaceuticals Additional Risk Indicators
The analysis of Rigel Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Rigel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Rigel Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.047 | |||
| Market Risk Adjusted Performance | 0.101 | |||
| Mean Deviation | 3.21 | |||
| Semi Deviation | 3.6 | |||
| Downside Deviation | 3.91 | |||
| Coefficient Of Variation | 2273.06 | |||
| Standard Deviation | 4.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Rigel Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Rigel Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Rigel Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Rigel Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Rigel Pharmaceuticals.
When determining whether Rigel Pharmaceuticals is a strong investment it is important to analyze Rigel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rigel Pharmaceuticals' future performance. For an informed investment choice regarding Rigel Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rigel Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 17.867 | Earnings Share 0.99 | Revenue Per Share | Quarterly Revenue Growth 0.609 | Return On Assets |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.